The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Aulock, S.
Right arrow Articles by Hermann, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Aulock, S.
Right arrow Articles by Hermann, C.
The Journal of Immunology, 2007, 178: 2610.
Copyright © 2007 by The American Association of Immunologists, Inc.


LETTERS TO THE EDITOR

Comment on "Not Lipoteichoic Acid but Lipoproteins Appear to Be the Dominant Immunobiologically Active Compounds in Staphylococcus aureus"

Sonja von Aulock, Thomas Hartung and Corinna Hermann

Biochemical Pharmacology, University of Konstanz, Konstanz, Germany

Recently, Hashimoto et al. (1) reported that lipoteichoic acid (LTA) extracted from a lipoprotein diacylglycerol transferase deletion ({Delta}lgt) mutant of Staphylococcus aureus is immunologically inactive and concluded that the activity of LTA preparations generally lies in lipoprotein contaminants. These conclusions challenge our published (2, 3, 4, 5) and unpublished results.

Although referenced, the authors fail to mention that a fully synthetic complete LTA analog reflects the immunostimulatory activity of LTA of bacterial origin (3, 4). This activity cannot stem from lipoproteins.

Since neither the authors nor we see signs of lipoproteins in the nuclear magnetic resonance analysis of butanol-extracted, octylsepharose-purified LTA preparations (1, 2), they would need to prove that purified lipoproteins are at least 100-fold more potent than LTA to be considered relevant immunostimulatory structures. However, they have not been able to isolate or identify such structures.

We prepared LTA from the {Delta}lgt mutant and respective wild-type bacteria by butanol extraction. Although we can confirm that LTA from the mutant does not stimulate the murine macrophage cell line J774A.1, the LTAs of both strains are equipotent in stimulating cytokine release in human whole blood (Fig. 1), arguably the more relevant system.


Figure 1
View larger version (14K):
[in this window]
[in a new window]

 
FIGURE 1. Similar activity of LTA from S. aureus DSM 20233, SA113 wild-type, and SA113 {Delta}lgt mutant. Human whole blood, diluted 1/5 in RPMI 1640, was stimulated overnight with LTA prepared as described previously (2 ). TNF release was measured in the supernatants by ELISA, n = 12 blood donors. Data are given as mean ± SEM.

 
Whether this difference between the two systems reflects a specific deficiency of the J774A.1 cell line or whether the LTA of the mutant strain is chemically modified, resulting in species-specific macrophage activation, is currently under investigation.

In conclusion, there remains strong evidence that LTAs are major immunostimulatory principles of Gram-positive bacteria. These data caution us from direct extrapolations from mice to humans.

References

  1. Hashimoto, M., K. Tawaratsumida, H. Kariya, A. Kiyohara, Y. Suda, F. Krikae, T. Kirikae, F. Gotz. 2006. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J. Immunol. 177: 3162-3169. [Abstract/Free Full Text]
  2. Morath, S., A. Geyer, T. Hartung. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193: 393-397. [Abstract/Free Full Text]
  3. Morath, S., A. Stadelmaier, A. Geyer, R. R. Schmidt, T. Hartung. 2002. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195: 1635-1640. [Abstract/Free Full Text]
  4. Deininger, S., A. Stadelmaier, S. von Aulock, S. Morath, R. R. Schmidt, T. Hartung. 2003. Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J. Immunol. 170: 4134-4138. [Abstract/Free Full Text]
  5. Morath, S., A. Geyer, I. Spreitzer, C. Hermann, T. Hartung. 2002. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect. Immun. 70: 938-944. [Abstract/Free Full Text]



This article has been cited by other articles:


Home page
CVIHome page
S. Meron-Sudai, A. Matityahou, Y. Keisari, K. H. Cox, D. L. Hasty, and I. Ofek
Lipoteichoic Acid Synergizes with Glycosphingolipids To Potently Stimulate Secretion of Interleukin-6 from Human Blood Cells
Clin. Vaccine Immunol., September 1, 2008; 15(9): 1309 - 1315.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Henneke, S. Dramsi, G. Mancuso, K. Chraibi, E. Pellegrini, C. Theilacker, J. Hubner, S. Santos-Sierra, G. Teti, D. T. Golenbock, et al.
Lipoproteins Are Critical TLR2 Activating Toxins in Group B Streptococcal Sepsis
J. Immunol., May 1, 2008; 180(9): 6149 - 6158.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Knapp, S. von Aulock, M. Leendertse, I. Haslinger, C. Draing, D. T. Golenbock, and T. van der Poll
Lipoteichoic Acid-Induced Lung Inflammation Depends on TLR2 and the Concerted Action of TLR4 and the Platelet-Activating Factor Receptor
J. Immunol., March 1, 2008; 180(5): 3478 - 3484.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. S. Seo, S. M. Michalek, and M. H. Nahm
Lipoteichoic Acid Is Important in Innate Immune Responses to Gram-Positive Bacteria
Infect. Immun., January 1, 2008; 76(1): 206 - 213.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
C. Hermann
Review: Variability of host pathogen interaction
Innate Immunity, August 1, 2007; 13(4): 199 - 218.
[Abstract] [PDF]


Home page
J. Immunol.Home page
M. Hashimoto, M. Furuyashiki, and Y. Suda
Response to Comment on "Not Lipoteichoic Acid but Lipoproteins Appear to Be the Dominant Immunobiologically Active Compounds in Staphylococcus aureus"
J. Immunol., March 1, 2007; 178(5): 2610 - 2611.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Aulock, S.
Right arrow Articles by Hermann, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Aulock, S.
Right arrow Articles by Hermann, C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS